USPTO serial 86214921
MOFFITT CANCER CENTER
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 18, 2014
- Examiner
- KERTGATE, AMY L
- Law office
- GENERIC WEB UPDATE
What this means
Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.
Need help with MOFFITT CANCER CENTER?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
H. Lee Moffitt Cancer Center and Research Institute, Inc.
Tampa, FL
Other trademarks owned by H. Lee Moffitt Cancer Center and Research Institute, Inc.
H. Lee Moffitt Cancer Center and Research Institute, Inc.
Tampa, FL
Other trademarks owned by H. Lee Moffitt Cancer Center and Research Institute, Inc.
H. Lee Moffitt Cancer Center and Research Institute, Inc.
Tampa, FL
Other trademarks owned by H. Lee Moffitt Cancer Center and Research Institute, Inc.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Corey K. Cho
Corey K. Cho SALIWANCHIK, LLOYD & EISENSCHENK, P.A.3107 SW Williston RoadGAINESVILLE, FL 32608United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 016 | Publications, namely, printed instructional and teaching materials, brochures, pamphlets, bulletins, newsletters and magazines, all in the field of health care, cancer protection, prevention, detection and treatment, medical diagnostics and prognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases | ACTIVE | Nov 30, 2007 |
| 041 | Medical educational services, namely, conducting lectures, seminars and workshops to health care practitioners, patients and patient caregivers in the field of health care, cancer care and prevention of cancer, and medical diagnostics, prognostics and the evaluation of drug and treatment effectiveness relating to cancer and other diseases | ACTIVE | Nov 30, 2007 |
| 042 | Providing an online database and depository for the collection of clinical and molecular data derived from a patient that is accessible by physicians, patients and researchers, namely, an online database in the field of human clinical and molecular data accumulation and analysis for aiding medical diagnostics, prognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases for research purposes; medical and clinical research resources in the field of cancer and other diseases, namely, providing data regarding tumor-specific molecular signatures and the effectiveness of a drug and/or diagnostic test for research purposes; medical and clinical research resources in the field of cancer and other diseases, namely, providing evidence-based treatment protocols by effectively comparing standard treatment therapies with clinical outcomes for research purposes; medical research services consisting of collection and analysis of data in the field of human clinical and molecular data for aiding medical diagnostics, prognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases, namely, matching particular patients to a particular drug, treatment, therapy or clinical trial by the specific molecular signature of the patient; collection and analysis of data services in the field of human clinical and molecular data accumulation and analysis for research assistance for medical diagnostics, prognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases, namely, providing objective data in usable form on the effectiveness of a drug or diagnostic test | ACTIVE | Dec 31, 2007 |
| 044 | Providing health care, medical information and counseling in the field of cancer; providing medical screening and diagnostic services with use of patient scanning equipment; providing an online computer database featuring medical information in the field of human clinical and molecular data accumulation and analysis for aiding medical diagnostics, prognostics and the evaluation and testing of drug and treatment effectiveness; medical services, namely, cancer care and prevention of cancer, and medical diagnostics, prognostics and evaluation of drug and treatment effectiveness relating to cancer and other diseases; medical counseling; telephone hot line counseling, namely, offering advice regarding cancer prevention, detection, treatment and clinical testing in the field of cancer and other diseases | ACTIVE | Nov 30, 2007 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by H. Lee Moffitt Cancer Center and Research Institute, Inc.
- Other trademarks owned by H. Lee Moffitt Cancer Center and Research Institute, Inc.
- Other trademarks owned by H. Lee Moffitt Cancer Center and Research Institute, Inc.
- Other trademarks in Class 016
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named MOFFITT CANCER CENTER
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 24, 2024 | NA89 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | — |
| Apr 24, 2024 | RNL1 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| Apr 24, 2024 | 89AG | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | The USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary. |
| Apr 24, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Dec 22, 2023 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Nov 18, 2023 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Mar 28, 2020 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Mar 28, 2020 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Mar 28, 2020 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jan 31, 2020 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Nov 18, 2019 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Nov 18, 2014 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 2, 2014 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 2, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 13, 2014 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 26, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 26, 2014 | ALIE | ASSIGNED TO LIE | — |
| Jul 15, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 14, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 14, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 14, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 21, 2014 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 21, 2014 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 21, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 12, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 21, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 11, 2014 | NWAP | NEW APPLICATION ENTERED | — |